Treatment of MOG antibody associated disorders: results of an international survey

While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) are increasingly diagnosed world-wide, consensus on management is yet to be developed. To survey the current global clinical practice of clinicians treating MOGAD. Neurologists worldwide with expertise in treating MOGAD participated in an online survey (February–April 2019). Fifty-two responses were received (response rate 60.5%)...